ASX - By Stock
|
CSL |
Re:
Ann: Top-line Results from the Phase 3 AEGIS-II Trial
|
|
bagus
|
44 |
21K |
0 |
14:09 |
14:09 |
ASX - By Stock
|
44
|
21K
|
0
|
|
ASX - By Stock
|
CSL |
Re:
Ann: CSL Australia Investor Site Tour Presentations
|
|
bagus
|
7 |
3.8K |
0 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
7
|
3.8K
|
0
|
|
ASX - By Stock
|
CSL |
Re:
Ann: CSL Australia Investor Site Tour Presentations
|
|
bagus
|
7 |
3.8K |
0 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
7
|
3.8K
|
0
|
|
ASX - By Stock
|
CSL |
Re:
Macquarie tips CSL shares to hit $500
|
|
bagus
|
2 |
1.8K |
1 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
2
|
1.8K
|
1
|
|
ASX - By Stock
|
CSL |
Re:
News: CSL Ferinject Approved By Health Canada For The Treatment Of Iron Deficiency Anemia In Adult...
|
|
bagus
|
5 |
3.2K |
2 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
5
|
3.2K
|
2
|
|
ASX - By Stock
|
CSL |
Re:
Ann: Statutory Accounts for the Half Year Ended 31 December 2023
|
|
bagus
|
52 |
25K |
1 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
52
|
25K
|
1
|
|
ASX - By Stock
|
CSL |
Re:
Ann: Statutory Accounts for the Half Year Ended 31 December 2023
|
|
bagus
|
52 |
25K |
4 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
52
|
25K
|
4
|
|
ASX - By Stock
|
CSL |
Re:
Ann: Statutory Accounts for the Half Year Ended 31 December 2023
|
|
bagus
|
52 |
25K |
3 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
52
|
25K
|
3
|
|
ASX - By Stock
|
CSL |
Re:
Ann: Statutory Accounts for the Half Year Ended 31 December 2023
|
|
bagus
|
52 |
25K |
0 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
52
|
25K
|
0
|
|
ASX - By Stock
|
CSL |
Re:
Ann: Statutory Accounts for the Half Year Ended 31 December 2023
|
|
bagus
|
52 |
25K |
3 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
52
|
25K
|
3
|
|
ASX - By Stock
|
CSL |
Re:
Ann: Statutory Accounts for the Half Year Ended 31 December 2023
|
|
bagus
|
52 |
25K |
1 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
52
|
25K
|
1
|
|
ASX - By Stock
|
CSL |
Re:
Ann: Half Year Results Investor Presentation
|
|
bagus
|
18 |
9.2K |
0 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
18
|
9.2K
|
0
|
|
ASX - By Stock
|
CSL |
Re:
Ann: Half Year Results Investor Presentation
|
|
bagus
|
18 |
9.2K |
0 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
18
|
9.2K
|
0
|
|
ASX - By Stock
|
CSL |
Re:
Ann: Half Year Results Investor Presentation
|
|
bagus
|
18 |
9.2K |
0 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
18
|
9.2K
|
0
|
|
ASX - By Stock
|
CSL |
Re:
Ann: Half Year Results Investor Presentation
|
|
bagus
|
18 |
9.2K |
1 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
18
|
9.2K
|
1
|
|
ASX - By Stock
|
CSL |
Re:
Ann: Half Year Results Investor Presentation
|
|
bagus
|
18 |
9.2K |
0 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
18
|
9.2K
|
0
|
|
ASX - By Stock
|
CSL |
Re:
Ann: Top-line Results from the Phase 3 AEGIS-II Trial
|
|
bagus
|
44 |
21K |
1 |
12/02/24 |
12/02/24 |
ASX - By Stock
|
44
|
21K
|
1
|
|
ASX - By Stock
|
CSL |
Re:
Ann: Top-line Results from the Phase 3 AEGIS-II Trial
|
|
bagus
|
44 |
21K |
0 |
12/02/24 |
12/02/24 |
ASX - By Stock
|
44
|
21K
|
0
|
|
ASX - By Stock
|
CSL |
Re:
Csl112
|
|
bagus
|
27 |
10K |
0 |
12/02/24 |
12/02/24 |
ASX - By Stock
|
27
|
10K
|
0
|
|
ASX - By Stock
|
CSL |
Re:
Ann: Top-line Results from the Phase 3 AEGIS-II Trial
|
|
bagus
|
44 |
21K |
0 |
12/02/24 |
12/02/24 |
ASX - By Stock
|
44
|
21K
|
0
|
|
ASX - By Stock
|
CSL |
Re:
Csl112
|
|
bagus
|
27 |
10K |
1 |
08/02/24 |
08/02/24 |
ASX - By Stock
|
27
|
10K
|
1
|
|
ASX - By Stock
|
CSL |
Re:
Csl112
|
|
bagus
|
27 |
10K |
0 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
27
|
10K
|
0
|
|
ASX - By Stock
|
CSL |
Re:
Csl112
|
|
bagus
|
27 |
10K |
1 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
27
|
10K
|
1
|
|
Charts
|
CSL |
Re:
CSL Chart
|
|
bagus
|
1.1K |
650K |
0 |
20/12/23 |
20/12/23 |
Charts
|
1.1K
|
650K
|
0
|
|
Charts
|
CSL |
Re:
CSL Chart
|
|
bagus
|
1.1K |
650K |
2 |
20/12/23 |
20/12/23 |
Charts
|
1.1K
|
650K
|
2
|
|
Charts
|
CSL |
Re:
dividend growth rate
|
|
bagus
|
15 |
7.8K |
2 |
22/11/23 |
22/11/23 |
Charts
|
15
|
7.8K
|
2
|
|
Charts
|
CSL |
Re:
dividend growth rate
|
|
bagus
|
15 |
7.8K |
1 |
21/11/23 |
21/11/23 |
Charts
|
15
|
7.8K
|
1
|
|
ASX - By Stock
|
CSL |
Re:
Smartest guys in the room
|
|
bagus
|
10 |
5.7K |
2 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
10
|
5.7K
|
2
|
|
ASX - By Stock
|
CSL |
Re:
Smartest guys in the room
|
|
bagus
|
10 |
5.7K |
0 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
10
|
5.7K
|
0
|
|
Charts
|
CSL |
Re:
CSL Chart
|
|
bagus
|
1.1K |
650K |
2 |
30/10/23 |
30/10/23 |
Charts
|
1.1K
|
650K
|
2
|
|
ASX - By Stock
|
CSL |
Re:
Ann: CSL Capital Markets Day
|
|
bagus
|
10 |
6.8K |
1 |
26/10/23 |
26/10/23 |
ASX - By Stock
|
10
|
6.8K
|
1
|
|
Charts
|
CSL |
Re:
CSL Chart
|
|
bagus
|
1.1K |
650K |
0 |
17/10/23 |
17/10/23 |
Charts
|
1.1K
|
650K
|
0
|
|
Charts
|
CSL |
Re:
CSL Chart
|
|
bagus
|
1.1K |
650K |
0 |
13/10/23 |
13/10/23 |
Charts
|
1.1K
|
650K
|
0
|
|
Charts
|
CSL |
Re:
CSL Chart
|
|
bagus
|
1.1K |
650K |
2 |
13/10/23 |
13/10/23 |
Charts
|
1.1K
|
650K
|
2
|
|
Charts
|
CSL |
Re:
CSL Chart
|
|
bagus
|
1.1K |
650K |
2 |
13/10/23 |
13/10/23 |
Charts
|
1.1K
|
650K
|
2
|
|
ASX - By Stock
|
CSL |
Re:
Ann: CSL 2023 AGM Chair and CEO Speech and Presentation
|
|
bagus
|
18 |
9.4K |
0 |
12/10/23 |
12/10/23 |
ASX - By Stock
|
18
|
9.4K
|
0
|
|
Charts
|
CSL |
Re:
Is Aegros a genuine Threat to CSL?
|
|
bagus
|
79 |
67K |
2 |
12/10/23 |
12/10/23 |
Charts
|
79
|
67K
|
2
|
|
Charts
|
CSL |
Re:
Is Aegros a genuine Threat to CSL?
|
|
bagus
|
79 |
67K |
1 |
12/10/23 |
12/10/23 |
Charts
|
79
|
67K
|
1
|
|
Charts
|
CSL |
Re:
Is Aegros a genuine Threat to CSL?
|
|
bagus
|
79 |
67K |
0 |
12/10/23 |
12/10/23 |
Charts
|
79
|
67K
|
0
|
|
Charts
|
CSL |
Re:
Is Aegros a genuine Threat to CSL?
|
|
bagus
|
79 |
67K |
1 |
12/10/23 |
12/10/23 |
Charts
|
79
|
67K
|
1
|
|
Charts
|
CSL |
Re:
Is Aegros a genuine Threat to CSL?
|
|
bagus
|
79 |
67K |
4 |
12/10/23 |
12/10/23 |
Charts
|
79
|
67K
|
4
|
|
Charts
|
CSL |
Re:
Is Aegros a genuine Threat to CSL?
|
|
bagus
|
79 |
67K |
2 |
12/10/23 |
12/10/23 |
Charts
|
79
|
67K
|
2
|
|
Charts
|
CSL |
Re:
Is Aegros a genuine Threat to CSL?
|
|
bagus
|
79 |
67K |
2 |
12/10/23 |
12/10/23 |
Charts
|
79
|
67K
|
2
|
|
ASX - By Stock
|
CSL |
Re:
Ann: CSL 2023 AGM Chair and CEO Speech and Presentation
|
|
bagus
|
18 |
9.4K |
2 |
12/10/23 |
12/10/23 |
ASX - By Stock
|
18
|
9.4K
|
2
|
|
Charts
|
CSL |
Re:
Is Aegros a genuine Threat to CSL?
|
|
bagus
|
79 |
67K |
1 |
12/10/23 |
12/10/23 |
Charts
|
79
|
67K
|
1
|
|
Charts
|
CSL |
Re:
Is Aegros a genuine Threat to CSL?
|
|
bagus
|
79 |
67K |
1 |
12/10/23 |
12/10/23 |
Charts
|
79
|
67K
|
1
|
|
Charts
|
CSL |
Re:
Is Aegros a genuine Threat to CSL?
|
|
bagus
|
79 |
67K |
4 |
12/10/23 |
12/10/23 |
Charts
|
79
|
67K
|
4
|
|
Charts
|
CSL |
Re:
Is Aegros a genuine Threat to CSL?
|
|
bagus
|
79 |
67K |
2 |
12/10/23 |
12/10/23 |
Charts
|
79
|
67K
|
2
|
|
Charts
|
CSL |
Re:
Is Aegros a genuine Threat to CSL?
|
|
bagus
|
79 |
67K |
0 |
12/10/23 |
12/10/23 |
Charts
|
79
|
67K
|
0
|
|
ASX - By Stock
|
CSL |
Re:
Ann: Final Director's Interest Notice
|
|
bagus
|
3 |
1.3K |
1 |
12/10/23 |
12/10/23 |
ASX - By Stock
|
3
|
1.3K
|
1
|
|